Metraipolis › archive › dc_e893f383fe44

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis — Europe PMC PMID:42181212

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42181212
DOI: 10.3389/fendo.2026.1817400
License (as archived): solo-consultazione
Archived: 2026-11-02T13:30:44.350Z
SHA-256 of the archived text: 8489eac104f77b13f275095851994ee8d2afafc3cac06b03485c60d880a58298
Stable URL of this page: https://metraipolis.com/documento/dc_e893f383fe44

How to cite

Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis — Europe PMC PMID:42181212 — Europe PMC (en), https://europepmc.org/article/MED/42181212 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e893f383fe44 (Metraipolis archive dc_e893f383fe44, sha256 8489eac104f77b13f275095851994ee8d2afafc3cac06b03485c60d880a58298)

BibTeX

@misc{dce893f383fe44,
  title = {Therapeutic targets for diabetic nephropathy identified by druggable genome mendelian randomization: the role of the gut microbiota-metabolite axis — Europe PMC PMID:42181212},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42181212},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e893f383fe44; sha256 8489eac104f77b13f275095851994ee8d2afafc3cac06b03485c60d880a58298},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42181212. Agents can read the archived copy with the MCP tool read_document.